# LI-COR

> LI-COR is a VC fund in Lincoln backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Lincoln, United States
- Total investments: 2
- Last investment: Dec 2017
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/li-cor-biosciences
- Website: https://x.com/licor_env
- Facebook: https://www.facebook.com/LICORenv/

LI-COR is a VC fund in Lincoln focused on Health Care and Biotechnology. LI-COR Biosciences is an innovator in developing high-quality instrument systems used for plant research, gas analysis, drug discovery, protein research, and small animal imaging. The company’s instruments, analysis software, and reagents are used in more than one hundred countries, and the International Space Station, for studies ranging fromglobal climate change to cancer research. LI-COR employs more than 300 employees at its headquarters in Lincoln, NE, USA, and subsidiaries in Bad Homburg, Germany, and Cambridge, UK. The company’s mission is “Impacting Lives Through Science.” LI-COR strives to improve the human condition through innovative research tools that help scientists solve the challenges that face humanity.

## Contacts

5 contacts available for LI-COR. Shizune tracks 3 team members at LI-COR. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/li-cor?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Graham Leggett | Senior Scientist, Marketing - Environmental | 0 | — |
| Rocco Tuccio | Senior Design Engineer, Software | 0 | — |
| Thomas Reslewic | CEO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aura Biosciences | Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives ofpeople with a wide range of cancers that are poorly managed today.The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts. | $30M | Series C | Dec 21, 2017 |  |
| Aura Biosciences | Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives ofpeople with a wide range of cancers that are poorly managed today.The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts. | $21M | Series B | Mar 05, 2015 |  |

2 of 2 investments shown.

## Co-investors
- [Advent Life Sciences](https://shizune.co/investors/profile/advent-life) — VC Fund, 3 deals together
- [Ysios Capital](https://shizune.co/investors/profile/ysios-capital) — VC Fund, 3 deals together
- [Arix Bioscience](https://shizune.co/investors/profile/arix-bioscience) — VC Fund, 2 deals together
- [Chiesi Ventures](https://shizune.co/investors/profile/chiesi-ventures) — VC Fund, 2 deals together
- [Alexandria](https://shizune.co/investors/profile/alexandria-venture) — VC Fund, 1 deal together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does LI-COR invest in?

LI-COR invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact LI-COR?

Public channels for LI-COR include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LI-COR?

The team at LI-COR includes Graham Leggett (Senior Scientist, Marketing - Environmental), Rocco Tuccio (Senior Design Engineer, Software) and Thomas Reslewic (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co